back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-16 00:42 Tx date 2020-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-350,000 vol |
450,000 | |
| Filed 2024-05-16 00:39 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+150,000 vol $0.05 each |
750,000 | |
| Filed 2024-05-15 14:56 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
50 - Grant of options
|
$5,000
+100,000 vol $0.05 each |
350,000 | |
| Filed 2024-05-15 14:52 Tx date 2024-05-09 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+150,000 vol $0.05 each |
725,000 | |
| Filed 2024-01-19 08:49 Tx date 2020-08-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-19 08:48 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
250,000 | |
| Filed 2024-01-19 08:45 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+250,000 vol $0.03 each |
1,000,000 | |
| Filed 2024-01-19 08:43 Tx date 2023-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
1,250,000 | |
| Filed 2024-01-19 08:40 Tx date 2022-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
750,000 | |
| Filed 2024-01-19 08:39 Tx date 2021-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
500,000 | |
| Filed 2024-01-19 08:38 Tx date 2020-08-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,500
+250,000 vol $0.13 each |
||
| Filed 2024-01-19 08:34 Tx date 2020-08-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Larsen, Grant
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-21 01:18 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2023-04-21 01:16 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
575,000 | |
| Filed 2023-04-20 14:00 Tx date 2023-04-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,500
+150,000 vol $0.03 each |
950,000 | |
| Filed 2023-01-13 13:05 Tx date 2022-11-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
12,268,800 | |
| Filed 2022-11-30 15:41 Tx date 2022-11-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
||
| Filed 2022-11-30 15:42 Tx date 2022-11-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,400
+285,000 vol $0.04 each |
12,553,800 | |
| Filed 2022-11-30 15:41 Tx date 2022-11-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+115,000 vol $0.03 each |
12,268,800 | |
| Filed 2022-09-07 16:18 Tx date 2022-09-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,290
+47,000 vol $0.07 each |
368,500 | |
| Filed 2022-09-07 16:17 Tx date 2022-09-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+10,000 vol $0.06 each |
321,500 | |
| Filed 2022-09-06 16:46 Tx date 2022-09-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,850
+90,000 vol $0.065 each |
311,500 | |
| Filed 2022-08-29 08:45 Tx date 2021-02-26 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+3,333,333 vol |
3,333,333 | |
| Filed 2022-08-29 08:40 Tx date 2021-02-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-29 08:39 Tx date 2021-02-26 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$999,999
+6,666,666 vol $0.15 each |
6,666,666 | |
| Filed 2022-08-26 19:49 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+20,000 vol $0.065 each |
250,000 | |
| Filed 2022-08-26 19:48 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$960.00
+16,000 vol $0.06 each |
230,000 | |
| Filed 2022-08-26 19:46 Tx date 2022-07-25 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,480
+64,000 vol $0.07 each |
214,000 | |
| Filed 2022-08-26 19:45 Tx date 2022-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,820
+26,000 vol $0.07 each |
150,000 | |
| Filed 2022-08-26 19:44 Tx date 2022-07-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+4,000 vol $0.07 each |
124,000 | |
| Filed 2022-08-26 19:43 Tx date 2022-07-20 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,400
+120,000 vol $0.07 each |
120,000 | |
| Filed 2022-08-26 19:42 Tx date 2021-02-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-20 15:11 Tx date 2022-07-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+100,000 vol $0.075 each |
12,153,800 | |
| Filed 2022-07-19 14:48 Tx date 2022-07-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80.00
+1,000 vol $0.08 each |
12,053,800 | |
| Filed 2022-07-19 14:48 Tx date 2022-07-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,930
+99,000 vol $0.07 each |
12,052,800 | |
| Filed 2022-04-25 12:28 Tx date 2021-12-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-84,000
-240,000 vol $0.35 each |
300,000 | |
| Filed 2022-04-01 20:57 Tx date 2022-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
11,953,800 | |
| Filed 2021-09-01 19:08 Tx date 2021-09-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,500
+500,000 vol $0.145 each |
11,958,800 | |
| Filed 2021-06-02 17:03 Tx date 2021-06-02 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,720
+200,000 vol $0.1586 each |
11,458,800 | |
| Filed 2021-04-28 18:17 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,900
+74,500 vol $0.20 each |
11,258,800 | |
| Filed 2021-04-28 18:15 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,055
+184,500 vol $0.19 each |
11,184,300 | |
| Filed 2021-04-28 18:14 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,585
+41,000 vol $0.185 each |
10,999,800 | |
| Filed 2021-04-28 17:58 Tx date 2017-02-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-90,000 vol |
0 | |
| Filed 2021-04-28 17:47 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$185.00
+1,000 vol $0.185 each |
||
| Filed 2021-04-28 17:47 Tx date 2021-04-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$185.00
+1,000 vol $0.185 each |
10,959,800 | |
| Filed 2021-04-05 17:49 Tx date 2021-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$187,500
+1,562,500 vol $0.12 each |
10,958,800 | |
| Filed 2021-04-05 17:48 Tx date 2021-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-187,500
-1,562,500 vol $0.12 each |
90,000 | |
| Filed 2021-04-05 17:33 Tx date 2021-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$7,500
+62,500 vol $0.12 each |
221,500 | |
| Filed 2021-04-05 17:30 Tx date 2021-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-62,500 vol |
0 | |
| Filed 2021-03-24 20:15 Tx date 2014-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
350,000 | |
| Filed 2021-03-24 20:14 Tx date 2014-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-15 15:32 Tx date 2014-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-03-17 04:09 Tx date 2014-12-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Chris
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-17 01:31 Tx date 2021-02-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Lustig, Marc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
350,000 | ||
| Filed 2021-01-18 13:30 Tx date 2021-01-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,750
+70,000 vol $0.125 each |
9,396,300 | |
| Filed 2021-01-18 13:29 Tx date 2021-01-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,600
+130,000 vol $0.12 each |
9,326,300 | |
| Filed 2021-01-04 13:10 Tx date 2020-12-31 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+100,000 vol $0.11 each |
9,196,300 | |
| Filed 2021-01-04 13:08 Tx date 2020-12-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,100
+100,000 vol $0.101 each |
9,096,300 | |
| Filed 2020-12-14 23:06 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Christopher John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
800,000 | |
| Filed 2020-12-14 14:55 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Flowerday, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,750
+350,000 vol $0.105 each |
800,000 | |
| Filed 2020-12-11 13:43 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
50 - Grant of options
|
$7,875
+75,000 vol $0.105 each |
150,000 | |
| Filed 2020-12-11 13:41 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,500
+100,000 vol $0.105 each |
275,000 | |
| Filed 2020-12-09 12:22 Tx date 2020-12-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,600
+200,000 vol $0.103 each |
8,996,300 | |
| Filed 2020-12-03 12:53 Tx date 2020-12-01 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,200
+150,000 vol $0.108 each |
8,796,300 | |
| Filed 2020-11-02 13:57 Tx date 2020-10-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,687
+21,500 vol $0.125 each |
8,646,300 | |
| Filed 2020-10-20 16:12 Tx date 2020-10-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,150
+150,000 vol $0.101 each |
8,624,800 | |
| Filed 2020-08-11 23:14 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+312,500 vol |
312,500 | |
| Filed 2020-08-11 23:11 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 23:11 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+625,000 vol $0.08 each |
625,000 | |
| Filed 2020-08-11 23:09 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 23:08 Tx date 2020-02-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
350,000 | |
| Filed 2020-08-11 23:06 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-10 21:56 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+62,500 vol |
62,500 | |
| Filed 2020-08-10 21:54 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-10 21:54 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$10,000
+125,000 vol $0.08 each |
159,000 | |
| Filed 2020-08-10 14:52 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$187,500
+1,562,500 vol $0.12 each |
1,652,500 | |
| Filed 2020-08-10 14:45 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+3,125,000 vol $0.08 each |
8,474,800 | |
| Filed 2020-06-10 11:46 Tx date 2020-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,910
+46,000 vol $0.085 each |
5,349,800 | |
| Filed 2020-06-10 11:44 Tx date 2020-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,320
+54,000 vol $0.08 each |
5,303,800 | |
| Filed 2020-06-10 11:43 Tx date 2020-06-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,000
+100,000 vol $0.08 each |
5,249,800 | |
| Filed 2019-05-23 12:25 Tx date 2019-03-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,925
-13,000 vol $0.225 each |
0 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
540,000 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
175,000 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
440,000 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Rodoula
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+452,941 vol |
452,941 | |
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
1,724,337 | |
| Filed 2017-12-12 Tx date 2015-02-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Rodoula
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-12 Tx date 2015-02-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-11 Tx date 2017-12-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Clark, Christopher John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
450,000 | |
| Filed 2017-12-09 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Flowerday, Jason
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,500
+100,000 vol $0.195 each |
450,000 | |
| Filed 2017-09-21 Tx date 2017-09-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,040
+19,000 vol $0.16 each |
5,149,800 | |
| Filed 2017-09-21 Tx date 2017-09-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,770
+281,000 vol $0.17 each |
5,130,800 | |
| Filed 2017-09-13 Tx date 2017-09-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,125
+25,000 vol $0.165 each |
4,849,800 | |
| Filed 2017-08-02 Tx date 2017-07-28 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,255
+11,000 vol $0.205 each |
4,824,800 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,250
+10,000 vol $0.225 each |
4,813,800 | |
| Filed 2017-07-14 Tx date 2017-07-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,450
+15,000 vol $0.23 each |
4,803,800 | |
| Filed 2017-06-21 Tx date 2017-06-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+13,000 vol $0.24 each |
4,788,800 | |
| Filed 2017-06-21 Tx date 2017-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,327
+9,500 vol $0.245 each |
4,775,800 | |
| Filed 2017-06-21 Tx date 2017-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,120
+25,500 vol $0.24 each |
4,766,300 | |
| Filed 2017-05-05 Tx date 2017-05-05 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+50,000 vol $0.25 each |
4,740,800 | |
| Filed 2017-05-05 Tx date 2017-05-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,465
+45,500 vol $0.23 each |
4,690,800 | |
| Filed 2016-11-16 Tx date 2016-11-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$405.00
+1,500 vol $0.27 each |
13,000 | |
| Filed 2016-10-21 Tx date 2016-10-20 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,160
+6,000 vol $0.36 each |
4,645,300 | |
| Filed 2016-10-06 Tx date 2016-09-13 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$10,200
+34,000 vol $0.30 each |
34,000 | |
| Filed 2016-10-06 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-26 Tx date 2016-09-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,385
+9,000 vol $0.265 each |
4,639,300 | |
| Filed 2016-09-26 Tx date 2016-09-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+21,000 vol $0.25 each |
4,630,300 | |
| Filed 2016-09-19 Tx date 2016-09-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,610
+9,000 vol $0.29 each |
4,609,300 | |
| Filed 2016-09-19 Tx date 2016-09-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$285.00
+1,000 vol $0.285 each |
4,600,300 | |
| Filed 2016-09-13 Tx date 2016-09-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$249,090
+830,300 vol $0.30 each |
4,599,300 | |
| Filed 2016-08-02 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2016-08-02 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Holder: Fehr & Associates (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-02 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2016-08-02 Tx date 2016-07-22 |
$AQS
Aequus Pharmaceuticals Inc. |
Fehr, Ann
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-30 Tx date 2016-05-20 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,585
-5,500 vol $0.47 each |
11,500 | |
| Filed 2016-05-30 Tx date 2016-05-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-460.00
-1,000 vol $0.46 each |
17,000 | |
| Filed 2016-05-06 Tx date 2016-05-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,800
+140,000 vol $0.47 each |
1,424,337 | |
| Filed 2016-05-06 Tx date 2016-04-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,800
+140,000 vol $0.47 each |
||
| Filed 2016-05-06 Tx date 2016-05-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+2,500 vol $0.45 each |
6,078,958 | |
| Filed 2016-05-06 Tx date 2016-05-03 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,369
+3,000 vol $0.4566 each |
6,076,458 | |
| Filed 2016-05-06 Tx date 2016-05-06 |
$AQS
Aequus Pharmaceuticals Inc. |
McAfee, Donald
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,800
+40,000 vol $0.47 each |
100,000 | |
| Filed 2016-05-06 Tx date 2016-05-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$65,800
+140,000 vol $0.47 each |
140,000 | |
| Filed 2016-05-06 Tx date 2015-07-28 |
$AQS
Aequus Pharmaceuticals Inc. |
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-01 Tx date 2016-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,530
+3,000 vol $0.51 each |
6,073,458 | |
| Filed 2016-04-01 Tx date 2016-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,855
+3,500 vol $0.53 each |
6,070,458 | |
| Filed 2016-04-01 Tx date 2016-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
6,066,958 | |
| Filed 2016-04-01 Tx date 2016-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,225
+2,500 vol $0.49 each |
6,064,958 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$495.00
+1,000 vol $0.495 each |
6,062,458 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,187
+2,500 vol $0.475 each |
6,061,458 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,525
+7,500 vol $0.47 each |
6,058,958 | |
| Filed 2016-03-31 Tx date 2016-03-28 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+5,000 vol $0.47 each |
3,769,000 | |
| Filed 2016-03-21 Tx date 2016-03-17 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$41,979
+83,958 vol $0.50 each |
6,051,458 | |
| Filed 2016-03-21 Tx date 2016-03-17 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,425
+3,000 vol $0.475 each |
5,967,500 | |
| Filed 2016-03-21 Tx date 2016-03-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,520
+12,000 vol $0.46 each |
5,964,500 | |
| Filed 2016-02-29 Tx date 2016-02-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,000
+6,000 vol $0.50 each |
3,764,000 | |
| Filed 2016-02-18 Tx date 2016-02-18 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,850
+10,000 vol $0.485 each |
3,758,000 | |
| Filed 2016-02-18 Tx date 2016-02-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,880
+12,000 vol $0.49 each |
3,748,000 | |
| Filed 2016-01-15 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
5,952,500 | |
| Filed 2016-01-14 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+5,000 vol $0.53 each |
5,942,500 | |
| Filed 2016-01-14 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+5,000 vol $0.54 each |
5,937,500 | |
| Filed 2015-12-25 Tx date 2015-12-23 |
$AQS
Aequus Pharmaceuticals Inc. |
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,250
+235,000 vol $0.55 each |
350,000 | |
| Filed 2015-12-18 Tx date 2015-12-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,734
+27,000 vol $0.4346 each |
5,932,500 | |
| Filed 2015-12-18 Tx date 2015-12-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,734
+27,000 vol $0.4346 each |
||
| Filed 2015-11-30 Tx date 2015-11-26 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$610.00
+1,000 vol $0.61 each |
3,736,000 | |
| Filed 2015-11-30 Tx date 2015-11-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,360
+6,000 vol $0.56 each |
3,735,000 | |
| Filed 2015-11-23 Tx date 2015-11-23 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+5,000 vol $0.52 each |
3,729,000 | |
| Filed 2015-11-17 Tx date 2015-11-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
3,724,000 | |
| Filed 2015-11-17 Tx date 2015-11-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
70 - Acquisition or disposition (writing) of third party derivative
|
$3,640
+7,000 vol $0.52 each |
3,714,000 | |
| Filed 2015-11-17 Tx date 2015-11-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
3,707,000 | |
| Filed 2015-11-17 Tx date 2015-11-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,350
+5,000 vol $0.47 each |
3,697,000 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
5,905,500 | |
| Filed 2015-11-12 Tx date 2015-11-12 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+4,000 vol $0.50 each |
18,000 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+8,000 vol $0.50 each |
5,900,500 | |
| Filed 2015-11-06 Tx date 2015-11-03 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
5,892,500 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
3,692,000 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+5,000 vol $50.00 each |
3,690,000 | |
| Filed 2015-11-06 Tx date 2015-11-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,000
+5,000 vol $50.00 each |
3,685,000 | |
| Filed 2015-11-06 Tx date 2015-11-02 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,160
+8,000 vol $0.52 each |
3,680,000 | |
| Filed 2015-10-07 Tx date 2015-07-28 |
$AQS
Aequus Pharmaceuticals Inc. |
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,259,200 | ||
| Filed 2015-10-07 Tx date 2014-07-28 |
$AQS
Aequus Pharmaceuticals Inc. |
Ball, Ian Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-20 Tx date 2015-09-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$265.00
+500 vol $0.53 each |
5,882,500 | |
| Filed 2015-09-20 Tx date 2015-09-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,480
+12,000 vol $0.54 each |
5,882,000 | |
| Filed 2015-09-08 Tx date 2015-09-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,200
+4,000 vol $0.55 each |
3,672,000 | |
| Filed 2015-08-24 Tx date 2015-08-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+3,000 vol $0.62 each |
3,668,000 | |
| Filed 2015-08-19 Tx date 2015-08-10 |
$AQS
Aequus Pharmaceuticals Inc. |
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,750
+25,000 vol $0.55 each |
28,000 | |
| Filed 2015-08-16 Tx date 2015-08-13 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,900
+5,000 vol $0.58 each |
3,665,000 | |
| Filed 2015-08-16 Tx date 2015-08-11 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,850
+7,000 vol $0.55 each |
3,660,000 | |
| Filed 2015-07-17 Tx date 2015-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,240
+3,500 vol $0.64 each |
3,647,000 | |
| Filed 2015-07-17 Tx date 2015-07-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$945.00
+1,500 vol $0.63 each |
3,643,500 | |
| Filed 2015-07-17 Tx date 2015-07-16 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,080
+6,000 vol $0.68 each |
3,653,000 | |
| Filed 2015-06-18 Tx date 2015-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
5,865,000 | |
| Filed 2015-06-18 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,080
+2,000 vol $0.54 each |
3,642,000 | |
| Filed 2015-06-18 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,640
+7,000 vol $0.52 each |
3,640,000 | |
| Filed 2015-06-18 Tx date 2015-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,450
+5,000 vol $0.49 each |
5,870,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+5,000 vol $0.57 each |
5,860,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,050
+11,000 vol $0.55 each |
5,855,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,860
+9,000 vol $0.54 each |
5,844,000 | |
| Filed 2015-06-12 Tx date 2015-06-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,699
+10,000 vol $0.57 each |
5,835,000 | |
| Filed 2015-06-12 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,704
+6,500 vol $0.57 each |
5,825,000 | |
| Filed 2015-06-12 Tx date 2015-05-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,994
+3,500 vol $0.57 each |
5,818,500 | |
| Filed 2015-06-12 Tx date 2015-06-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$900.00
+1,500 vol $0.60 each |
3,633,000 | |
| Filed 2015-06-12 Tx date 2015-06-12 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,994
+3,500 vol $0.57 each |
3,631,500 | |
| Filed 2015-06-12 Tx date 2015-06-10 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+2,000 vol $0.60 each |
3,628,000 | |
| Filed 2015-06-12 Tx date 2015-06-10 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,770
+3,000 vol $0.59 each |
3,626,000 | |
| Filed 2015-06-12 Tx date 2015-06-09 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,950
+5,000 vol $0.59 each |
3,623,000 | |
| Filed 2015-06-09 Tx date 2015-06-08 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,720
+6,000 vol $0.62 each |
3,618,000 | |
| Filed 2015-06-09 Tx date 2015-06-03 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,490
+9,000 vol $0.61 each |
3,612,000 | |
| Filed 2015-05-27 Tx date 2015-05-27 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,840
+6,000 vol $0.64 each |
3,603,000 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,200
+5,000 vol $0.64 each |
3,597,000 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,260
+2,000 vol $0.63 each |
3,592,000 | |
| Filed 2015-05-22 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,880
+8,000 vol $0.61 each |
3,590,000 | |
| Filed 2015-05-22 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,180
+2,000 vol $0.59 each |
3,582,000 | |
| Filed 2015-05-19 Tx date 2015-05-19 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,500
+10,000 vol $0.65 each |
3,580,000 | |
| Filed 2015-05-19 Tx date 2015-05-15 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+10,000 vol $0.60 each |
3,570,000 | |
| Filed 2015-05-14 Tx date 2015-05-13 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,130
+7,000 vol $0.59 each |
5,815,000 | |
| Filed 2015-05-14 Tx date 2015-05-14 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+10,000 vol $0.60 each |
3,560,000 | |
| Filed 2015-05-11 Tx date 2015-05-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+4,000 vol $0.60 each |
5,808,000 | |
| Filed 2015-05-11 Tx date 2015-05-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,709
+3,000 vol $0.57 each |
5,804,000 | |
| Filed 2015-05-11 Tx date 2015-05-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+1,000 vol $0.60 each |
5,801,000 | |
| Filed 2015-04-30 Tx date 2015-04-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+4,000 vol $0.60 each |
14,000 | |
| Filed 2015-04-30 Tx date 2015-04-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+3,000 vol $0.60 each |
3,000 | |
| Filed 2015-04-30 Tx date 2015-03-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Shahbazi, Hamed
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-04-30 Tx date 2015-04-30 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+15,000 vol $0.60 each |
3,550,000 | |
| Filed 2015-04-30 Tx date 2015-04-29 |
$AQS
Aequus Pharmaceuticals Inc. |
JANZEN, DOUG
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+35,000 vol $0.60 each |
3,535,000 |